EUVIMEDEUVIMED entdecken
Crossref

Astragaloside IV plays a neuroprotective role by promoting PPARγ in cerebral ischemia-reperfusion rats

Yanping Ding, Kang Jie, Liu Xin, Baoping Shao

Behavioural Brain Research · 2025

DOI: 10.1016/j.bbr.2024.115267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Yanping Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Northwest Normal University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, PPAR gamma, Reperfusion Injury, Saponins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cerebral ischemia-reperfusion injury (CIRI) usually occurs during the treatment phase of ischemic disease, which is closely related to high morbidity and mortality. Promoting neurogenesis and synaptic plasticity are effective neural recovery strategies for CIRI. Astragaloside IV (AS-IV) has been shown to play a neuroprotective role in some neurological diseases. In the current study, we evaluated the effect and possible mechanism of AS-IV in CIRI rats. METHODS: The middle cerebral artery occlusion reperfusion (MCAO/R) model was established in rats to simulate the occurrence of human CIRI. First, we determined the cerebral injury on the 1st, 3rd, 5th and 7th day after cerebral ischemia-reperfusion (I/R) surgery by neurological deficit detection, TTC staining, TUNEL staining and Western blot analysis. Furthermore, rats were pre administered with AS-IV and then subjected to cerebral I/R surgery. Brains were collected on the 3rd day to evaluate the neuroprotective effect of AS-IV. RESULTS: Our results showed that on the 3rd day after I/R, the neurological impairment score and infarct volume were highest, the levels of apoptosis and expression of Caspase3 and Bax reached the peak. AS-IV treatment apparently attenuated neurological dysfunction, reduced infarct volume and pathological damage, promoted the neurogenesis, and alleviated the pathological damage caused by cerebral I/R involved in thickening and blurring of synaptic membranes, reduction of microtubules and synaptic vesicles, and loss of synaptic cleft. Our study also showed that AS-IV promoted the transcription and expression of the peroxisome proliferators-activated receptors γ (PPARγ) and brain-derived neurotrophic factor (BDNF), increased the expression of phosphorylation of tyrosine kinase receptor B (TrkB) and downstream PI3K/Akt/mTOR pathway proteins. Notably, when GW9662, an inhibitor of PPARγ was administered with AS-IV, the neuroprotective effect of AS-IV was reduced. CONCLUSIONS: These findings suggested that AS-IV has neuroprotective function in CIRI rats, and its molecular mechanism may depend on the phosphatidylinositide 3-kinase (PI3K)/protein kinase B (PKB)/Akt signalling pathway activated by PPARγ. AS-IV could be an effective therapeutic drug candidate for CIRI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsPPAR gammaReperfusion InjurySaponinsTriterpenesAnimalsMaleRatsApoptosisBrain IschemiaBrain-Derived Neurotrophic FactorDisease Models, AnimalInfarction, Middle Cerebral ArteryProto-Oncogene Proteins c-aktRats, Sprague-DawleySignal Transduction

Stichwörter der Autor:innen

Astragaloside IVBDNFCerebral ischemia-reperfusionPI3K/Akt/mTOR pathwayPPARγ

Substanzen

astragaloside ABrain-Derived Neurotrophic FactorNeuroprotective AgentsPPAR gammaPPAR gamma, ratProto-Oncogene Proteins c-aktSaponinsTriterpenes

Autor:innen und Institutionen

  • School of Life Science, Northwest Normal University, Lanzhou 730000, China.
  • School of Life Science, Lanzhou University, Lanzhou 730000, China.
  • School of Life Science, Lanzhou University, Lanzhou 730000, China. Electronic address: shaobp@lzu.edu.cn.

Förderung

  • Natural Science Foundation of Gansu Province
  • National Natural Science Foundation of China

Zitieren

APA

Ding, Y., Jie, K., Xin, L., & Shao, B. (2025). Astragaloside IV plays a neuroprotective role by promoting PPARγ in cerebral ischemia-reperfusion rats. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115267

Vancouver

Ding Y, Jie K, Xin L, Shao B. Astragaloside IV plays a neuroprotective role by promoting PPARγ in cerebral ischemia-reperfusion rats. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2024.115267

BibTeX
@article{Ding2025,
  author = {Ding, Yanping and Jie, Kang and Xin, Liu and Shao, Baoping},
  title = {Astragaloside IV plays a neuroprotective role by promoting PPARγ in cerebral ischemia-reperfusion rats},
  journal = {Behavioural Brain Research},
  year = {2025},
  doi = {10.1016/j.bbr.2024.115267}
}
Kostenlos starten →